1-2 of 2
Mohamed Abdel-Mohsen
Close
Sort by
Journal Articles

CRISPR-Cas9 Knock out of CD5 Enhances the Anti-Tumor Activity of Chimeric Antigen Receptor T Cells

Inkook Chun, MS, Ki Hyun Kim, PhD, Yi-Hao Chiang, MD, Wei Xie, MD, Yong Gu Gu Lee, PhD, Raymone Pajarillo, MS, Antonia Rotolo, MD PhD, Olga Shestova, PhD, Seok Jae Hong, MS, Mohamed Abdel-Mohsen, PhD, Maria Wysocka, PhD, Hatcher J. Ballard, BS, David M. Barrett, Avery D. Posey, PhD, Daniel Powell, Jr., PhD, Saar I. Gill, MDPhD, Stephen J. Schuster, MD, Stefan K. Barta, MDMRCP,MS, Alain H Rook, MD, Carl H June, MD, Marco Ruella, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–52.
https://doi.org/10.1182/blood-2020-136860
Published: 2020
Journal Articles

Single Chain Variable Fragment Linker Length Regulates CAR Biology and T Cell Efficacy

Nathan Singh, MD, Noelle V. Frey, MD, Boris Engels, PhD, David M. Barrett, Olga Shestova, PhD, Pranali Ravikumar, MS, Amy Shyu, Steven Highfill, PhD, Linlin Zhao, Liaomin Peng, Brian Granda, Melissa Ramones, Xeuqing Maggie Lu, David A Christian, PhD, Jessica Perazzelli, Simon F Lacey, PhD, Nathan Roy, Janis K Burkhardt, PhD, Florent Colomb, Mohamed Abdel-Mohsen, Regina M Young, PhD, Jennifer Brogdon, PhD, Stephan Grupp, MD PhD, Carl H June, MD, Shannon L. Maude, MD PhD, Saar I. Gill, MD PhD, Marco Ruella, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 247.
https://doi.org/10.1182/blood-2019-131024
Published: 2019